logo

Biotech Stocks Facing FDA Decision In June 2019

Pending Drug Approvals
Pending Drug Approvals

2018 marked an epic year for novel drug approvals - with the tally surging to 59, smashing all previous records. In 2017, only 46 novel drugs were approved.

Now, let's take a look at the biotech stocks that await a ruling from the FDA in June 2019.

Share